Atlas Trials

Prophylaxis of A/H3N2v Influenza

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Prophylaxis of A/H3N2v Influenza

RecordFirmDate
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older. (NCT01855945)Novartis Vaccines2013-05-01

Track Prophylaxis of A/H3N2v Influenza automatically

Every clearance here is in the API, with alerts when new ones post.